Walter V. Klemp, CEO and President at Moleculin Biotech, Inc. (MBRX), bought 22,500 shares at $1.15 ($26K) on 2022-11-21, disclosed to the SEC on 2022-11-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MBRX | BUY | 2022-11-28 | $58K | — | Filing → |
| MBRX | BUY | 2022-11-18 | $191K | — | Filing → |
| MBRX | SELL | 2017-08-18 | $170K | — | Filing → |